Cargando…
Advancing regulatory science for medical countermeasure development : workshop summary /
Whether or not the United States has safe and effective medical countermeasures--such as vaccines, drugs, and diagnostic tools--available for use during a disaster can mean the difference between life and death for many Americans. The Food and Drug Administration (FDA) and the scientific community a...
| Clasificación: | Libro Electrónico |
|---|---|
| Autores Corporativos: | , |
| Otros Autores: | , , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Washington, D.C. :
Natlional Academies Press,
©2011.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | EBOOKCENTRAL_ocn748588094 | ||
| 003 | OCoLC | ||
| 005 | 20240329122006.0 | ||
| 006 | m o d | ||
| 007 | cr cn||||||||| | ||
| 008 | 110831s2011 dcua ob 100 0 eng d | ||
| 040 | |a NRC |b eng |e rda |e pn |c NRC |d IDEBK |d N$T |d E7B |d CDX |d ORU |d UMR |d OCLCQ |d YDXCP |d OCLCO |d OCLCQ |d OCLCA |d DKDLA |d OCLCQ |d OCLCO |d OCLCA |d NLGGC |d OCLCA |d OCLCQ |d EBLCP |d DEBSZ |d OCLCQ |d OCLCA |d AZK |d JBG |d LOA |d OCLCO |d VT2 |d OCLCQ |d OCLCO |d TOA |d AGLDB |d MOR |d PIFAG |d ZCU |d OCLCQ |d MERUC |d OCLCQ |d OCLCO |d OCLCA |d U3W |d OCLCA |d BUF |d OCLCO |d MERER |d CUY |d OCLCQ |d OCLCO |d OCLCF |d STF |d OCLCO |d WRM |d VNS |d OCLCO |d OCLCQ |d VTS |d OCLCO |d COCUF |d NRAMU |d EZ9 |d OCLCQ |d AU@ |d OCLCQ |d WYU |d LVT |d S9I |d REC |d OCLCQ |d DKC |d OCLCO |d OCLCQ |d OCLCO |d M8D |d KIJ |d OCLCQ |d UKAHL |d OCLCQ |d OCLCA |d UKCRE |d BOL |d OCLCO |d OCLCQ |d SFB |d OCLCO |d OCLCQ |d OCLCO |d OCLCL |d OCLCQ |d OCLCL | ||
| 016 | 7 | |a 015906292 |2 Uk | |
| 019 | |a 754086593 |a 754329264 |a 758986075 |a 759907748 |a 816861532 |a 819379336 |a 923284117 |a 961513861 |a 962580553 |a 966220061 |a 971081227 |a 988407883 |a 991913269 |a 1021254420 |a 1028786573 |a 1037912119 |a 1038636196 |a 1047524358 |a 1048117325 |a 1055310955 |a 1062936400 |a 1081181109 |a 1114443739 |a 1119522543 |a 1125506672 |a 1153463827 |a 1156326080 |a 1204385074 |a 1204394289 |a 1228562827 |a 1249250282 | ||
| 020 | |a 9780309214919 |q (electronic bk.) | ||
| 020 | |a 0309214912 |q (electronic bk.) | ||
| 020 | |a 1283253542 | ||
| 020 | |a 9781283253543 | ||
| 020 | |a 9786613253545 | ||
| 020 | |a 6613253545 | ||
| 020 | |z 0309214904 | ||
| 020 | |z 9780309214902 | ||
| 024 | 8 | |a 9786613253545 | |
| 029 | 1 | |a AU@ |b 000051457889 | |
| 029 | 1 | |a DEBBG |b BV043039347 | |
| 029 | 1 | |a DEBBG |b BV044109290 | |
| 029 | 1 | |a DEBSZ |b 421519673 | |
| 029 | 1 | |a DEBSZ |b 452578604 | |
| 029 | 1 | |a GBVCP |b 803631960 | |
| 035 | |a (OCoLC)748588094 |z (OCoLC)754086593 |z (OCoLC)754329264 |z (OCoLC)758986075 |z (OCoLC)759907748 |z (OCoLC)816861532 |z (OCoLC)819379336 |z (OCoLC)923284117 |z (OCoLC)961513861 |z (OCoLC)962580553 |z (OCoLC)966220061 |z (OCoLC)971081227 |z (OCoLC)988407883 |z (OCoLC)991913269 |z (OCoLC)1021254420 |z (OCoLC)1028786573 |z (OCoLC)1037912119 |z (OCoLC)1038636196 |z (OCoLC)1047524358 |z (OCoLC)1048117325 |z (OCoLC)1055310955 |z (OCoLC)1062936400 |z (OCoLC)1081181109 |z (OCoLC)1114443739 |z (OCoLC)1119522543 |z (OCoLC)1125506672 |z (OCoLC)1153463827 |z (OCoLC)1156326080 |z (OCoLC)1204385074 |z (OCoLC)1204394289 |z (OCoLC)1228562827 |z (OCoLC)1249250282 | ||
| 037 | |a 325354 |b MIL | ||
| 043 | |a n-us--- | ||
| 050 | 4 | |a RA645.5 |b .A38 2011 ebook | |
| 060 | 4 | |a WX 186 | |
| 072 | 7 | |a HEA |x 033000 |2 bisacsh | |
| 072 | 7 | |a MED |x 003010 |2 bisacsh | |
| 072 | 7 | |a MBP |2 bicssc | |
| 082 | 0 | 4 | |a 362.18 |2 23 |
| 049 | |a UAMI | ||
| 245 | 0 | 0 | |a Advancing regulatory science for medical countermeasure development : |b workshop summary / |c Theresa Wizemann, Bruce M. Altevogt, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Forum on Medical and Public Health PreparadnessforCatastropicEvents, Board on Health Sciences Policy, Institute of Medicine of the National Academies. |
| 260 | |a Washington, D.C. : |b Natlional Academies Press, |c ©2011. | ||
| 300 | |a 1 online resource (xviii, 132 pages) : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 340 | |g polychrome. |2 rdacc |0 http://rdaregistry.info/termList/RDAColourContent/1003 | ||
| 347 | |a data file | ||
| 504 | |a Includes bibliographical references (pages 81-82). | ||
| 520 | |a Whether or not the United States has safe and effective medical countermeasures--such as vaccines, drugs, and diagnostic tools--available for use during a disaster can mean the difference between life and death for many Americans. The Food and Drug Administration (FDA) and the scientific community at large could benefit from improved scientific tools and analytic techniques to undertake the complex scientific evaluation and decision making needed to make essential medical countermeasures available. At the request of FDA, the Institute of Medicine (IOM) held a workshop to examine methods to improve the development, evaluation, approval, and regulation of medical countermeasures. During public health emergencies such as influenza or chemical, biological, radiological/nuclear (CBRN) attacks, safe and effective vaccines, treatments, and other medical countermeasures are essential to protecting national security and the well being of the public. Advancing Regulatory Science for Medical Countermeasure Development examines current medical countermeasures, and investigates the future of research and development in this area. Convened on March 29-30, 2011, this workshop identified regulatory science tools and methods that are available or under development, as well as major gaps in currently available regulatory science tools. Advancing Regulatory Science for Medical Countermeasure Development is a valuable resource for federal agencies including the Food and Drug Administration (FDA), the Department of Health and Human Services (HHS), the Department of Defense (DoD), as well as health professionals, and public and private health organizations"--Publisher's description | ||
| 505 | 0 | |a Introduction -- MCM enterprise and stakeholder perspectives -- Cutting-edge efforts to advance MCM regulatory science -- MCM regulatory science needs for at-risk populations -- Crosscutting themes and future directions -- Closing remarks. | |
| 588 | 0 | |a Print version record. | |
| 546 | |a English. | ||
| 590 | |a ProQuest Ebook Central |b Ebook Central Academic Complete | ||
| 590 | |a eBooks on EBSCOhost |b EBSCO eBook Subscription Academic Collection - Worldwide | ||
| 610 | 1 | 0 | |a United States. |b Food and Drug Administration |v Congresses. |
| 610 | 1 | 7 | |a United States. |b Food and Drug Administration |2 fast |
| 650 | 0 | |a Emergency management |z United States |x Evaluation |v Congresses. | |
| 650 | 0 | |a Disaster medicine |z United States |x Evaluation |v Congresses. | |
| 650 | 0 | |a Weapons of mass destruction |x Health aspects |v Congresses. | |
| 650 | 0 | |a Chemical agents (Munitions) |v Congresses. | |
| 650 | 1 | 2 | |a Disaster Planning |x organization & administration |
| 650 | 1 | 2 | |a Emergency Medical Services |x organization & administration |
| 651 | 2 | |a United States | |
| 650 | 6 | |a Médecine de catastrophes |z États-Unis |x Évaluation |v Congrès. | |
| 650 | 6 | |a Agents chimiques (Munitions) |v Congrès. | |
| 650 | 7 | |a HEALTH & FITNESS |x First Aid. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Allied Health Services |x Emergency Medical Services. |2 bisacsh | |
| 650 | 7 | |a Chemical agents (Munitions) |2 fast | |
| 650 | 7 | |a Emergency management |x Evaluation |2 fast | |
| 651 | 7 | |a United States |2 fast |1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq | |
| 655 | 2 | |a Congress | |
| 655 | 4 | |a Electronic resource. | |
| 655 | 7 | |a proceedings (reports) |2 aat | |
| 655 | 7 | |a Conference papers and proceedings |2 fast | |
| 655 | 7 | |a Conference papers and proceedings. |2 lcgft | |
| 655 | 7 | |a Actes de congrès. |2 rvmgf | |
| 700 | 1 | |a Wizemann, Theresa M. | |
| 700 | 1 | |a Altevogt, Bruce M. | |
| 700 | 1 | |a Claiborne, Anne B. | |
| 710 | 2 | |a Institute of Medicine (U.S.). |b Forum on Drug Discovery, Development, and Translation. | |
| 710 | 2 | |a Institute of Medicine (U.S.). |b Forum on Medical and Public Health Preparedness for Catastrophic Events. | |
| 758 | |i has work: |a Advancing regulatory science for medical countermeasure development (Text) |1 https://id.oclc.org/worldcat/entity/E39PCFq66Rm7RQ3K6KP9xGxDpX |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |t Advancing regulatory science for medical countermeasure development. |d Washington, D.C. : Natlional Academies Press, ©2011 |z 9780309214902 |w (OCoLC)744284130 |
| 856 | 4 | 0 | |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3378855 |z Texto completo |
| 938 | |a Askews and Holts Library Services |b ASKH |n AH36617411 | ||
| 938 | |a Askews and Holts Library Services |b ASKH |n AH36559627 | ||
| 938 | |a Coutts Information Services |b COUT |n 18795009 | ||
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL3378855 | ||
| 938 | |a ebrary |b EBRY |n ebr10495455 | ||
| 938 | |a EBSCOhost |b EBSC |n 396594 | ||
| 938 | |a ProQuest MyiLibrary Digital eBook Collection |b IDEB |n 325354 | ||
| 938 | |a YBP Library Services |b YANK |n 7222085 | ||
| 994 | |a 92 |b IZTAP | ||